BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Palleon Pharmaceuticals

Palleon Pharmaceuticals logo

Founded
2016
Geography
United States of America based
Funding
$47.600 M

Palleon Pharmaceuticals develops drugs that target sugar-sensing molecules on the surfaces of cells. It has integrated technologies and insights from world-renowned scientific leaders in glycoscience and human immunology to create the first Glycoimmune Checkpoint Inhibitors to treat cancer patients.

Technologies

Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet